{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T14:57:07Z","timestamp":1770562627270,"version":"3.49.0"},"reference-count":49,"publisher":"Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glob Health Sci Pract"],"published-print":{"date-parts":[[2022,4,28]]},"DOI":"10.9745\/ghsp-d-21-00122","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T13:50:15Z","timestamp":1650289815000},"page":"e2100122","source":"Crossref","is-referenced-by-count":3,"title":["Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project"],"prefix":"10.9745","volume":"10","author":[{"given":"Lisa","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren D.","family":"Kudrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everline","family":"Bosek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Mukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mugambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Masyuko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Mugurungi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imelda","family":"Mahaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Hettema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudo A.P.","family":"Kuwengwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindy","family":"Matse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiqa","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letitia","family":"Greener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diantha","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Mellors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvi M.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Global Evaluation of Microbicide Sensitivity (GEMS) project","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4690","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"2022092608000641000_10.2.e2100122.1","unstructured":"World Health Organization (WHO). Policy Brief: Pre-Exposure Prophylaxis: WHO Expands Recommendation on Oral Pre-Exposure Prophylaxis of HIV Infection (PrEP). WHO; 2015. Accessed March 26, 2022. https:\/\/apps.who.int\/iris\/handle\/10665\/197906"},{"key":"2022092608000641000_10.2.e2100122.2","doi-asserted-by":"publisher","DOI":"10.1071\/SH18090"},{"key":"2022092608000641000_10.2.e2100122.3","unstructured":"Country updates. PrEP Watch. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/in-practice\/country-updates\/"},{"key":"2022092608000641000_10.2.e2100122.4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30002-5"},{"key":"2022092608000641000_10.2.e2100122.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01143-8"},{"key":"2022092608000641000_10.2.e2100122.6","doi-asserted-by":"publisher","DOI":"10.17269\/CJPH.108.6254"},{"key":"2022092608000641000_10.2.e2100122.7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001145"},{"key":"2022092608000641000_10.2.e2100122.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1917"},{"key":"2022092608000641000_10.2.e2100122.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz896"},{"key":"2022092608000641000_10.2.e2100122.10","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000209"},{"key":"2022092608000641000_10.2.e2100122.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"2022092608000641000_10.2.e2100122.12","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001960"},{"key":"2022092608000641000_10.2.e2100122.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70847-3"},{"key":"2022092608000641000_10.2.e2100122.14","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01108-x"},{"key":"2022092608000641000_10.2.e2100122.15"},{"key":"2022092608000641000_10.2.e2100122.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1611639"},{"key":"2022092608000641000_10.2.e2100122.17","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001534"},{"key":"2022092608000641000_10.2.e2100122.18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001825"},{"key":"2022092608000641000_10.2.e2100122.19","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(18)30288-1"},{"key":"2022092608000641000_10.2.e2100122.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy321"},{"key":"2022092608000641000_10.2.e2100122.21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1011"},{"key":"2022092608000641000_10.2.e2100122.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.014"},{"key":"2022092608000641000_10.2.e2100122.23","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12989"},{"key":"2022092608000641000_10.2.e2100122.24","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25419"},{"key":"2022092608000641000_10.2.e2100122.25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001577"},{"key":"2022092608000641000_10.2.e2100122.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2221-3"},{"key":"2022092608000641000_10.2.e2100122.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191294"},{"key":"2022092608000641000_10.2.e2100122.28","unstructured":"World Health Organization (WHO). HIV Drug Resistance Report 2021. WHO; 2021. Accessed March 28, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240038608"},{"key":"2022092608000641000_10.2.e2100122.29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz667"},{"key":"2022092608000641000_10.2.e2100122.30","unstructured":"World Health Organization (WHO). HIV Drug Resistance Surveillance in Countries Scaling Up Pre-Exposure Prophylaxis. WHO; 2020. Accessed March 28, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240009813"},{"key":"2022092608000641000_10.2.e2100122.31","unstructured":"Parikh UM Kudrick L Levy L . High rates of drug resistance in individuals diagnosed with HIV in tenofovir disoproxil fumarate (TDF)-based pre-exposure prophylaxis rollout programs in Kenya, Zimbabwe, Eswatini and South Africa. Presented at: International AIDS Symposium (IAS); July 18-21, 2021; virtual conference. Accessed March 28, 2022. https:\/\/theprogramme.ias2021.org\/Abstract\/Abstract\/2585"},{"key":"2022092608000641000_10.2.e2100122.32","unstructured":"World Health Organization (WHO). WHO Manual for HIV Drug Resistance Testing Using Dried Blood Spot Specimens. WHO; 2020. Accessed March 28, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240009424"},{"key":"2022092608000641000_10.2.e2100122.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2008.00196.x"},{"issue":"4","key":"2022092608000641000_10.2.e2100122.34","first-page":"195","article-title":"Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance","volume":"12","author":"Bertagnolio","year":"2010","journal-title":"AIDS Rev"},{"key":"2022092608000641000_10.2.e2100122.35","unstructured":"Global Evaluation of Microbicide Sensitivity (GEMS). Pre-Exposure Prophylaxis (PrEP) and HIV Drug Resistance: Training Materials for Healthcare Workers. GEMS; 2017. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/wp-content\/uploads\/2017\/12\/PrEP_Drug_Resistance_Training_Slides.pdf"},{"key":"2022092608000641000_10.2.e2100122.36","unstructured":"Global Evaluation of Microbicide Sensitivity (GEMS). Dried Blood Spot (DBS) Job Aid for Resistance Testing. GEMS; 2018. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/wp-content\/uploads\/2018\/04\/DBS_Job_Aid_venipuncture.pdf"},{"key":"2022092608000641000_10.2.e2100122.37","unstructured":"Global Evaluation of Microbicide Sensitivity (GEMS). Acute Seroconversion Assessment for PrEP Provision. GEMS; 2017. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/wp-content\/uploads\/2017\/12\/Seroconversion_Checklist.pdf"},{"key":"2022092608000641000_10.2.e2100122.38","unstructured":"Global Evaluation of Microbicide Sensitivity (GEMS). Monitoring and Evaluation (M&E) Plan for Drug Resistance Programs. GEMS; 2017. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/resource\/recs-for-monitoring-and-evaluation-drug-resistance-prep-program\/"},{"key":"2022092608000641000_10.2.e2100122.39","unstructured":"Ndlovu N Parikh UM Kudrick L . Understanding the characteristics of HIV seroconverters and circumstances around Seroconversion in Zimbabwe with PrEP use. Presented at: Research for Prevention (R4P); January 27\u201328 and February 3\u20134, 2021; Virtual."},{"key":"2022092608000641000_10.2.e2100122.40","unstructured":"Chohan B Bosek E Mukui I . Monitoring of HIV drug resistance among seroconverters on PrEP in Kenya. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI); March 8\u201311, 2020; Boston, MA."},{"key":"2022092608000641000_10.2.e2100122.41","unstructured":"A snapshot of PrEP scale-up, registration and resources for Kenya. PrEP Watch. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/country\/kenya\/"},{"key":"2022092608000641000_10.2.e2100122.42","unstructured":"A snapshot of PrEP scale-up, registration and resources for Zimbabwe. PrEP Watch. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/country\/zimbabwe\/"},{"key":"2022092608000641000_10.2.e2100122.43","unstructured":"A snapshot of PrEP scale-up, registration and resources for Eswatini. PrEP Watch. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/country\/eswatini\/"},{"key":"2022092608000641000_10.2.e2100122.44","unstructured":"Track global PrEP use. PrEP Watch. Accessed March 28, 2022. https:\/\/www.prepwatch.org\/in-practice\/global-prep-tracker\/"},{"key":"2022092608000641000_10.2.e2100122.45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz667"},{"key":"2022092608000641000_10.2.e2100122.46","unstructured":"Riddler S Balkus JE Mellors J . NNRTI-containing ART is effective for dapivirine ring breakthrough HIV-1 infection. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI) 2017; Seattle, WA."},{"key":"2022092608000641000_10.2.e2100122.47","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25833"},{"key":"2022092608000641000_10.2.e2100122.48","unstructured":"World Health Organization (WHO). Global Action Plan on HIV Drug Resistance 2017\u20132021. WHO; 2017. https:\/\/www.who.int\/publications\/i\/item\/978-92-4-151284-8"},{"key":"2022092608000641000_10.2.e2100122.49","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000344"}],"container-title":["Global Health: Science and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9745\/GHSP-D-21-00122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T11:01:25Z","timestamp":1664190085000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ghspjournal.org\/lookup\/doi\/10.9745\/GHSP-D-21-00122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,29]]},"published-print":{"date-parts":[[2022,4,28]]}},"alternative-id":["10.9745\/GHSP-D-21-00122"],"URL":"https:\/\/doi.org\/10.9745\/ghsp-d-21-00122","relation":{},"ISSN":["2169-575X"],"issn-type":[{"value":"2169-575X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]}}}